Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
Quick Stats
Jan 30, 202654.1
AI Score
HOLD1.83
Volume Ratio
Mar 26, 2026
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
JBIO Stock Summary
Last updated Jan 30, 2026
JBIO is currently trading at $15.61, positioned below its 200-day moving average of $None, suggesting bearish momentum. The stock has a 52-week range of $6.565 to $17.71.
Technical Analysis: The 50-day moving average stands at $14.41, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.682, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.205, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates JBIO at 54.1/100 with a HOLD recommendation.
JBIO (Jade Biosciences, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.682 |
| CMF (20) | 0.205 |
| ROC (10) | 6.19 |
| ADX (14) | 15.373 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.431 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -32.189 |
| MFI (14) | 53.729 |
JBIO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
JBIO Price vs Max Options Open Interest
JBIO Max Change In Options Open Interest
JBIO Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JBIO Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JBIO Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JBIO Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Jade Biosciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
JBIO Moving Averages Analysis
Jade Biosciences, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
JBIO (Jade Biosciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 15.66 |
| 20 | 14.7 |
| 30 | 15.24 |
| 50 | 14.41 |
| 100 | 11.71 |
| 200 | None |
JBIO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 280.1 million |
| Earnings/Share ($) | -- |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | 0 |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 16.6667 |
| Most Recent Quarter |